- Home
- RVPH vs RAND Comparison
RVPH vs RAND Comparison
Compare RVPH & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- RAND
- Stock Information
- Founded
- RVPH 2006
- RAND 1969
- Country
- RVPH United States
- RAND United States
- Employees
- RVPH N/A
- RAND N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- RVPH Health Care
- RAND Finance
- Exchange
- RVPH Nasdaq
- RAND Nasdaq
- Market Cap
- RVPH 37.1M
- RAND 47.5M
- IPO Year
- RVPH N/A
- RAND N/A
- Fundamental
- Price
- RVPH $1.45
- RAND $16.77
- Analyst Decision
- RVPH Strong Buy
- RAND
- Analyst Count
- RVPH 5
- RAND 0
- Target Price
- RVPH $14.50
- RAND N/A
- AVG Volume (30 Days)
- RVPH 264.7K
- RAND 1.3K
- Earning Date
- RVPH 11-12-2024
- RAND 11-04-2024
- Dividend Yield
- RVPH N/A
- RAND 6.92%
- EPS Growth
- RVPH N/A
- RAND 72.67
- EPS
- RVPH N/A
- RAND 4.19
- Revenue
- RVPH N/A
- RAND $7,874,601.00
- Revenue This Year
- RVPH N/A
- RAND N/A
- Revenue Next Year
- RVPH N/A
- RAND N/A
- P/E Ratio
- RVPH N/A
- RAND $4.00
- Revenue Growth
- RVPH N/A
- RAND 13.24
- 52 Week Low
- RVPH $0.60
- RAND $12.50
- 52 Week High
- RVPH $6.80
- RAND $19.60
- Technical
- Relative Strength Index (RSI)
- RVPH 62.27
- RAND 48.90
- Support Level
- RVPH $1.15
- RAND $16.39
- Resistance Level
- RVPH $1.54
- RAND $17.26
- Average True Range (ATR)
- RVPH 0.11
- RAND 0.28
- MACD
- RVPH 0.02
- RAND 0.00
- Stochastic Oscillator
- RVPH 82.00
- RAND 43.68
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.